ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1462

Fibrin Deposition and Neutrophil Infiltration of Rheumatoid Arthritis Synovium Are Associated with Duration of Morning Stiffness

Dana Orange1, Caroline Jiang1, Edward F. DiCarlo2, Tania Pannellini3, Laura T. Donlin4, Serene Z. Mirza5, Mark P. Figgie6, Vivian P. Bykerk7, Ana-Maria Orbai8, Sarah Mackie9 and Susan M. Goodman3, 1Rockefeller University, New York, NY, 2Laboratory Medicine, Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York, NY, 4Arthritis and Tissue Degeneration Program and the David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, 5Rheumatology, Hospital for Special Surgery, New York, NY, 6Surgery, Hospital for Special Surgery, New York, NY, 7Deptartment of Rheumatology, Hospital for Special Surgery, New York, NY, 8Johns Hopkins University School of Medicine, Baltimore, MD, 9NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, University of Leeds, Leeds, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Disease Activity, histopathologic, outcomes and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Stiffness is a hallmark of RA, but little is known about the etiology. We investigated stiffness association with RA disease activity and determined whether synovial histologic features are associated with stiffness severity or stiffness duration. 

Methods: 194 patients with RA meeting ACR criteria undergoing arthroplasty were included (Table 1).  Morning stiffness duration was determined using the RADAI question, “Were your joints stiff when you woke up today?  If yes, how long did the stiffness last?”; “no stiffness, <30 min, 30-60 mins, 1-2 hrs, 2-4 hrs, >4 hrs, all day”. Stiffness severity was measured by the OMERACT Flare question, "How severe was your stiffness over the past week" on a 10 point Likert scale. Histopathology of synovium was scored for 10 features: synovial lining hyperplasia, lymphocytes, plasma cells, Russell bodies, binucleate plasma cells, fibrin, synovial giant cells detritus, neutrophils and mucin. Severity was modeled as a continuous outcome and duration was modeled as a binary outcome using < 30 mins vs ≥ 30 mins. Simple regression models were performed to examine the association between DAS28-ESR and RAPID3, with severity and duration. Multivariable regression models were performed with (either DAS28-ESR or RAPID3) and the following clinical variables: age, gender, BMI, duration of diagnosis, anti-CCP, and RF. Chi-squared or Fisher’s exact test was used to test the association between 10 histology features and morning stiffness outcomes. FDR-adjusted p-values were reported to correct for multiple comparisons.

Results: Morning stiffness duration of greater than 30 minutes was significantly associated with both DAS28-ESR (OR: 1.79 [1.26, 2.55], p value =0.001) and RAPID3 (OR: 1.17 [1.06, 1.29], p value =0.002) and remained significantly associated after incorporating age, gender, BMI, duration of diagnosis, anti-CCP and RF. Stiffness severity was also significantly associated with both DAS28 (β=0.51, p value =0.006) and RAPID3 (β =0.29, p value <0.0001) and remained significantly associated after incorporating age, gender, BMI, duration of diagnosis, anti-CCP, and RF into the model. After adjusting for multiple comparisons, neutrophils (Padj=0.005) and fibrin (Padj=0.005) were significantly associated with greater than 30 minutes of morning stiffness. None of the 10 synovial features examined were significantly associated with stiffness severity.

Conclusion: Both stiffness severity over the past week and duration of morning stiffness were significantly associated with the disease activity measurement instruments, DAS28 and RAPID3. Fibrin deposition and neutrophil infiltration are associated with the duration of morning stiffness in RA, suggesting acute synovial inflammation and relatively recent or ongoing neutrophil recruitment may play a role in the pathogenesis of this symptom.


Disclosure: D. Orange, None; C. Jiang, None; E. F. DiCarlo, None; T. Pannellini, None; L. T. Donlin, None; S. Z. Mirza, None; M. P. Figgie, None; V. P. Bykerk, None; A. M. Orbai, None; S. Mackie, PMRGCAuk, 6,PMR and GCA North East, 6,Sanofi, 5,GSK, 5; S. M. Goodman, Roche, Novartis, 4.

To cite this abstract in AMA style:

Orange D, Jiang C, DiCarlo EF, Pannellini T, Donlin LT, Mirza SZ, Figgie MP, Bykerk VP, Orbai AM, Mackie S, Goodman SM. Fibrin Deposition and Neutrophil Infiltration of Rheumatoid Arthritis Synovium Are Associated with Duration of Morning Stiffness [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/fibrin-deposition-and-neutrophil-infiltration-of-rheumatoid-arthritis-synovium-are-associated-with-duration-of-morning-stiffness/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibrin-deposition-and-neutrophil-infiltration-of-rheumatoid-arthritis-synovium-are-associated-with-duration-of-morning-stiffness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology